Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS Global Gender Equality UCITS ETF hCHF dis
IE00BDR5H305 · IE00BDR5H305 · CHF · domicile Ireland
equityCHF-hedged share classSFDR art. 8
Index tracked: Solactive Equileap Global Gender Equality 100 Leaders Index Hedged in CHF
- TER
- 0.23%+ trans. 0.01%
- Fund size
- —
- Tracking difference
- +0.20%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingsemi-annual
Launch 19 Dec 2017 · costs from the KID as of 26 Aug 2026
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Il Fondo è a gestione passiva e mira a replicare la performance dell'indice The Solactive Equileap Global Gender Equality 100 Leaders Net Total Return hedged to CHF Index (l'«Indice»).
L'Indice è concepito per generare un'esposizione ai risultati di borsa delle azioni delle società dei mercati sviluppati con un elevato punteggio per la diversità di genere ed evitare quelle con un basso punteggio per la diversità di genere. L'orientamento alle società con un elevato punteggio per la diversità di genere esclude almeno il 20% dei titoli con merito di…
Performance since series start (in euro) — base 100
19 Dec 2017 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +9.2% |
| 3 years | +38.6% |
| 5 years | +50.4% |
| 10 years | series too young |
| Since series start | +129.7% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 9.33% | 9.95% | 11.66% |
| Max drawdown | −7.26% | −13.10% | −21.70% |
| Sharpe | 0.54 | 0.57 | 0.11 |
| Sortino | 0.78 | 0.79 | 0.15 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BDR5H305 · IE00BDR5H3051
RebalixIE00BDR5H305 · IE00BDR5H305 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +13.17% | +12.96% | +0.21% |
| 2024 | +8.21% | +8.07% | +0.14% |
| 2023 | +11.60% | +11.35% | +0.25% |
| 2022 | −10.28% | −10.45% | +0.18% |
| 2021 | +17.72% | +17.73% | −0.01% |
Distributions · per share, in CHF
Frequency: semi-annual · last 12 months: 0.4012 CHF (2.26% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (CHF) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.4012 | — |
| 2025 | 2 | 0.2609 | +1.68% |
| 2024 | 2 | 0.3429 | +2.34% |
| 2023 | 2 | 0.3742 | +2.77% |
| 2022 | 2 | 0.3941 | +2.55% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BDR5H305
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BDR5H305
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE00BDR5H305 · IE00BDR5H3052